These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Tumor specific antigen appearance on normal cells during intermediate steps of viral carcinogenesis. Celada F. Boll Ist Sieroter Milan; 1971 Dec; 50(3):176-84. PubMed ID: 5169543 [No Abstract] [Full Text] [Related]
26. Production of tumor-specific antibody in the xenogeneic host: use of blocking antibody. Weiner RS, Hubbard JD, Mardiney MR. J Natl Cancer Inst; 1972 Oct; 49(4):1063-70. PubMed ID: 4117316 [No Abstract] [Full Text] [Related]
27. Studies on thymus products. I. Modification of rosette-forming cells by thymic extracts. Determination of the target RFC sub-population. Dardenne M, Bach JF. Immunology; 1973 Sep; 25(3):343-52. PubMed ID: 4542645 [Abstract] [Full Text] [Related]
28. Effect of thymus-derived lymphocytes on amount and affinity of anti-hapten antibody. Gershon RK, Paul WE. J Immunol; 1971 Mar; 106(3):872-4. PubMed ID: 5102123 [No Abstract] [Full Text] [Related]
32. [Column fractionation of immune cells. II. Characterization of fractionated immune cells by cell electrophoresis and indirect fluorescence with anti-theta serum]. Eckert R, Jenssen HL, Köhler H, Micheel B, Pasternak G. Acta Biol Med Ger; 1973 Aug; 31(1):139-48. PubMed ID: 4590303 [No Abstract] [Full Text] [Related]
33. The mechanism of immunological enhancement of H-2-incompatible skin grafts in mice. Chutná J. Transplantation; 1971 Jul; 12(1):28-35. PubMed ID: 4932695 [No Abstract] [Full Text] [Related]
34. Humoral antibody suppression with an anti-bone marrow serum. Mossing N, Claesson MH, Röpke C. Transplantation; 1976 Sep; 22(3):301-2. PubMed ID: 973244 [No Abstract] [Full Text] [Related]
35. Interaction of anti-thymocyte serum with haematopoietic stem cells. II. Stimulation of colony formation in vitro. Mookerjee BK, Poulter L. Immunology; 1974 Oct; 27(4):601-7. PubMed ID: 4140146 [Abstract] [Full Text] [Related]
36. Immunological response of adoptive transfer for the growth of Yoshida sarcoma. Ishikawa Y, Fukushima M, Sato T, Komaba M, Kakuta H. Gan; 1968 Dec; 59(6):453-60. PubMed ID: 5721580 [No Abstract] [Full Text] [Related]
37. Inhibition of cell-mediated cytotoxicity in the rat by anti-thymocyte serum. Sanderson CJ, Franks D. Immunology; 1974 Dec; 27(6):1045-51. PubMed ID: 4375670 [Abstract] [Full Text] [Related]
38. Characterization of the anti-stem cell activity of anti-mouse brain serum. Monette FC, Eichacker PQ, Garver RI, Byrt W, Gilio MJ. Exp Hematol; 1978 Mar; 6(3):299-310. PubMed ID: 648593 [Abstract] [Full Text] [Related]
39. Stem cell response to thrombocytopenia. Ebbe S, Phalen E, Overcash J, Howard D, Stohlman F. J Lab Clin Med; 1971 Dec; 78(6):872-81. PubMed ID: 4943503 [No Abstract] [Full Text] [Related]
40. [Recovery of the immunological response following thymectomy and irradiation]. Rosenthal M. Strahlentherapie; 1969 May; 137(5):596-611. PubMed ID: 4899640 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]